Dietary supplement GMP development should be higher CFSAN priority, CRN says.
This article was originally published in The Tan Sheet
Executive Summary
SUPPLEMENT GMP DEVELOPMENT HIGHER PRIORITY AT CFSAN URGED BY CRN Director of Scientific and Regulatory Affairs Annette Dickinson, PhD, at a Center for Food Safety & Applied Nutrition meeting in Washington, D.C. June 25. CFSAN called the public meeting to discuss its agenda and set priorities in light of Section 406 of the FDA Modernization Act that requires FDA to publish a plan for complying with its statutory obligations on the one-year anniversary of enactment of the law.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning